Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
S&P 500
Market Cap
48.78B
Enterprise Value
50.97B
Income
1.44B
Sales
7.37B
Book/sh
26.11
Cash/sh
6.24
Employees
18100
IPO
Nov 18, 1999
P/E
34.06
Forward P/E
25.69
PEG
2.57
P/S
6.62
P/B
6.63
P/C
27.75
P/FCF
38.50
EV/EBITDA
24.90
EV/Sales
6.91
Quick Ratio
1.56
Current Ratio
2.05
Debt/Eq
0.54
LT Debt/Eq
0.50
Option/Short
Yes / Yes
EPS (ttm)
5.08
EPS next Y
6.73
EPS next Q
1.73
EPS this Y
10.94%
EPS next Y
8.57%
EPS next 5Y
9.99%
EPS past 3/5Y
3.03% 14.68%
Sales past 3/5Y
0.48% 5.41%
EPS Y/Y TTM
19.07%
Sales Y/Y TTM
8.60%
EPS Q/Q
8.50%
Sales Q/Q
8.06%
Insider Own
0.32%
Insider Trans
-0.25%
Inst Own
95.56%
Inst Trans
1.06%
ROA
11.00%
ROE
20.97%
ROIC
13.08%
Gross Margin
53.72%
Oper. Margin
24.09%
Profit Margin
19.53%
SMA20
0.81%
SMA50
7.91%
SMA200
28.16%
Trades
Shs Outstand
281.97M
Shs Float
281.04M
52W High
177.47 -2.51%
52W Low
108.35 59.68%
Volatility
2.61% 3.00%
ATR (14)
4.57
RSI (14)
60.34
Beta
1.25
Rel Volume
0.00
Avg Volume
2.24M
Volume
9
Perf Week
-0.57%
Perf Month
3.44%
Perf Quarter
23.81%
Perf Half Y
43.61%
Perf YTD
27.15%
Perf Year
18.76%
Perf 3Y
58.39%
Perf 5Y
10.24%
Perf 10Y
279.66%
Prev Close
173.01
Price
173.01
Change %
0.00%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelDirectorSep 04 '26Sale151.3863495,9724,924Sep 09 04:01 PM
Dolsten MikaelDirectorSep 04 '26Proposed Sale151.3863495,972Sep 04 04:19 PM
Dolsten MikaelDirectorMay 29 '26Sale135.421,600216,6725,548Jun 02 04:01 PM
Dolsten MikaelDirectorMay 29 '26Proposed Sale135.421,600216,672May 29 04:45 PM
Dolsten MikaelDirectorDec 01 '25Sale149.812,600389,5114,973Dec 03 04:04 PM
Gonsalves RodneyV.P., Corporate ControllerNov 26 '25Sale154.993,000464,95631,846Dec 01 04:29 PM
Dolsten MikaelDirectorDec 01 '25Proposed Sale149.812,600389,510Dec 01 04:26 PM
Gonsalves RodneyOfficerNov 26 '25Proposed Sale154.993,000464,956Nov 26 02:26 PM
MCDONNELL PADRAIGPresident and CEONov 18 '25Sale143.24911130,49232,058Nov 20 05:22 PM
MCDONNELL PADRAIGOfficerNov 18 '25Proposed Sale143.24911130,492Nov 18 10:37 AM
MCDONNELL PADRAIGPresident and CEONov 12 '25Option Exercise109.8612,4901,372,15145,938Nov 14 04:02 PM
MCDONNELL PADRAIGPresident and CEONov 12 '25Sale150.0012,4901,873,50033,448Nov 14 04:02 PM
MCDONNELL PADRAIGOfficerNov 12 '25Proposed Sale150.0012,4901,873,500Nov 12 10:03 AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
CEOMr. Padraig McDonnell
Vice President of FinanceMr. Rodney Gonsalves
Senior VP & President of Agilent CrossLab GroupMs. Angelica A. Riemann
Senior VP and President of Life Sciences & Diagnostics Markets GroupDr. Simon May
Special AdvisorMr. Bret M. DiMarco